879 DOI: 10.1309/0773N4Q3GFP34J5V 879 © American Society for Clinical Pathology Anatomic Pathology / FASL AND BCL-2 IN CERVICAL CARCINOMA Expression of Fas Ligand and bcl-2 in Cervical Carcinoma and Their Prognostic Significance

Apoptosis-related factors are known to influence survival with many malignant tumors. We performed immunohistochemical analysis of Fas ligand (FasL) and bcl-2 in invasive cervical cancer to determine the association with prognosis. In 125 patients with cervical cancer, 93 cases (74.4%) were positive for FasL, and 94 cases (75.2%) were positive for bcl-2. When 101 cases, clinical stages I through IV, were analyzed by univariate analysis, negative bcl-2 (P =.035) and combined positive FasL and negative bcl-2 (PFNB; P =.0025) were associated with significantly decreased disease-free survival. Positive FasL (P =.042), negative bcl-2 (P =.0004), and PFNB (P <.0001) were associated with a significantly worse prognosis in overall survival. In clinical stages II through IV, positive FasL (P =.04), negative bcl-2 (P =.002), and PFNB (P <.0001) had significant associations with shorter disease-free survival an